Shenyi Yin

机构：Peking University, Annoroad Gene Technology (China) · ORCID：0000-0003-2731-5689

发表论文 61 篇 · 总被引 1271 次 · h-index 15

代表论文

• Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment (2024 · Cell · 被引 60)
• Patient-derived tumor-like cell clusters for personalized chemo- and immunotherapies in non-small cell lung cancer (2024 · Cell stem cell · 被引 43)
• Comprehensive Detection of PD-L1 Protein and mRNA in Tumor Cells and Extracellular Vesicles through a Real-Time qPCR Assay (2023 · Analytical Chemistry · 被引 15)
• Intratumoural vaccination via checkpoint degradation-coupled antigen presentation (2026 · Nature · 被引 13)
• High-throughput screening of spike variants uncovers the key residues that alter the affinity and antigenicity of SARS-CoV-2 (2023 · Cell Discovery · 被引 9)
• The interpretable multimodal dimension reduction framework SpaHDmap enhances resolution in spatial transcriptomics (2026 · Nature Cell Biology · 被引 7)